Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selected Concise Host Transcriptional Signatures for the Blood-based Diagnosis of Active Tuberculosis in an HIV-prevalent Setting (RNA-based Diagnosis of TB)

NCT05542511 is registered in ClinicalTrials.gov with University of Stellenbosch as lead sponsor.

NCT NCT05542511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05542511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selected Concise Host Transcriptional Signatures for the Blood-based Diagnosis of Active Tuberculosis in an HIV-prevalent Setting (RNA-based Diagnosis of TB)
Lead sponsor
University of Stellenbosch
Phase
Observational
Overall status
Active, not recruiting
Start date
June 23, 2022
Completion date
December 31, 2025
Enrollment
1,458 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lower respiratory infection, tuberculosis